Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

Preparing for introduction of a dengue vaccine: Recommendations from the 1st Dengue v2V Asia-Pacific Meeting

Lam, SK and Burke, D and Capeding, MR and Chong, CK and Coudeville, L and Farrar, J and Gubler, D and Hadinegoro, SR and Hanna, J and Lang, J and Lee, HL and Leo, YS and Luong, CQ and Mahoney, R and Mcbride, J and Mendez-Galvan, J and Ng, LC and Nimmannitya, S and Ooi, EE and Shepard, D and Smit, J and Teyssou, R and Thomas, L and Torresi, J and Vasconcelos, P and Wirawan, DN and Yoksan, S (2011) Preparing for introduction of a dengue vaccine: Recommendations from the 1st Dengue v2V Asia-Pacific Meeting. Vaccine, 29 (51). 9417 - 9422. ISSN 0264-410X

[img] Plain Text (licence)
Available under License : See the attached license file.

Download (1kB)

Abstract

Infection with dengue virus is a major public health problem in the Asia-Pacific region and throughout tropical and sub-tropical regions of the world. Vaccination represents a major opportunity to control dengue and several candidate vaccines are in development. Experts in dengue and in vaccine introduction gathered for a two day meeting during which they examined the challenges inherent to the introduction of a dengue vaccine into the national immunisation programmes of countries of the Asia-Pacific. The aim was to develop a series of recommendations to reduce the delay between vaccine licensure and vaccine introduction. Major recommendations arising from the meeting included: ascertaining and publicising the full burden and cost of dengue; changing the perception of dengue in non-endemic countries to help generate global support for dengue vaccination; ensuring high quality active surveillance systems and diagnostics; and identifying sustainable sources of funding, both to support vaccine introduction and to maintain the vaccination programme. The attendees at the meeting were in agreement that with the introduction of an effective vaccine, dengue is a disease that could be controlled, and that in order to ensure a vaccine is introduced as rapidly as possible, there is a need to start preparing now. © 2011 Elsevier Ltd.


Share

Citation/Export:
Social Networking:
Share |

Details

Item Type: Article
Status: Published
Creators/Authors:
CreatorsEmailPitt UsernameORCID
Lam, SK
Burke, Ddonburke@pitt.eduDONBURKE
Capeding, MR
Chong, CK
Coudeville, L
Farrar, J
Gubler, D
Hadinegoro, SR
Hanna, J
Lang, J
Lee, HL
Leo, YS
Luong, CQ
Mahoney, R
Mcbride, J
Mendez-Galvan, J
Ng, LC
Nimmannitya, S
Ooi, EE
Shepard, D
Smit, J
Teyssou, R
Thomas, L
Torresi, J
Vasconcelos, P
Wirawan, DN
Yoksan, S
Centers: Other Centers, Institutes, Offices, or Units > Center for Vaccine Research
Date: 1 January 2011
Date Type: Publication
Journal or Publication Title: Vaccine
Volume: 29
Number: 51
Page Range: 9417 - 9422
DOI or Unique Handle: 10.1016/j.vaccine.2011.08.047
Schools and Programs: Graduate School of Public Health > Epidemiology
Refereed: Yes
ISSN: 0264-410X
Article Type: Review
Date Deposited: 07 May 2015 19:27
Last Modified: 03 Aug 2019 14:55
URI: http://d-scholarship.pitt.edu/id/eprint/24406

Metrics

Monthly Views for the past 3 years

Plum Analytics

Altmetric.com


Actions (login required)

View Item View Item